切换至 "中华医学电子期刊资源库"

中华临床医师杂志(电子版) ›› 2024, Vol. 18 ›› Issue (05) : 474 -480. doi: 10.3877/cma.j.issn.1674-0785.2024.05.006

基础研究

CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究
靳英1,(), 付小霞1, 陈美茹1, 袁璐1, 郝力瑶1   
  1. 1. 034000 山西忻州,山西医科大学附属忻州医院病理科
  • 收稿日期:2024-04-10 出版日期:2024-05-15
  • 通信作者: 靳英
  • 基金资助:
    山西省自然科学基金(201901D111470); 山西省卫健委2021年度“四个一批”科技兴医创新计划(2021XM15)

CD147 promotes cell proliferation and reduces apoptosis in colon cancer cells by regulating the MAPK signaling pathway

Ying Jin1,(), Xiaoxia Fu1, Meiru Chen1, Lu Yuan1, Liyao Hao1   

  1. 1. Department of Pathology, Xinzhou Hospital, Shanxi Medical University, Xinzhou 034000, China
  • Received:2024-04-10 Published:2024-05-15
  • Corresponding author: Ying Jin
引用本文:

靳英, 付小霞, 陈美茹, 袁璐, 郝力瑶. CD147调控MAPK信号通路对结肠癌细胞增殖和凋亡的影响及机制研究[J]. 中华临床医师杂志(电子版), 2024, 18(05): 474-480.

Ying Jin, Xiaoxia Fu, Meiru Chen, Lu Yuan, Liyao Hao. CD147 promotes cell proliferation and reduces apoptosis in colon cancer cells by regulating the MAPK signaling pathway[J]. Chinese Journal of Clinicians(Electronic Edition), 2024, 18(05): 474-480.

目的

探讨CD147表达对结肠癌细胞增殖、凋亡的影响和潜在的分子机制。

方法

分析UCSC数据库中基因BSG(编码CD147蛋白)在结肠癌中的表达,利用Kaplan-Meier Plotter数据库评估BSG的表达与生存结局之间的关系。应用Western blot检测CD147在HCT116和HCoEPiC细胞中的表达,通过慢病毒转染HCT116细胞下调CD147表达进一步验证其转染效率。应用CCK-8、平板克隆和Hoechst 33342染色实验检测细胞增殖和凋亡能力。Western blot检测各组细胞内MAPK、p-MAPK、C-MYC、BAX和BCL-2的表达;同时应用TIMER 2.0数据库对结肠癌组织中的BSG表达和MAPK1、MYC、BAX、BCL-2进行相关性分析。

结果

UCSC数据库观察到CD147在结肠癌组织中表达高于正常组织(P<0.01);过表达CD147患者的预后不良。Western blot结果显示,与HCoEPiC细胞比较,HCT116细胞中CD147蛋白表达增高(P<0.001)。荧光显微镜下shCD147低表达组与sh-NON空载组细胞的荧光表达丰度均可达90%;Western blot结果显示,与HCT116细胞比较,shCD147组细胞中CD147蛋白表达降低(P<0.001)。下调CD147后,与HCT116组比较,sh-CD147组细胞增殖和细胞集落形成能力降低;Hoechst 33342染色结果显示,与HCT116组相比,shCD147组凋亡的细胞核染色增强,荧光更为明亮(P<0.001)。与HCT116相比,sh-CD147组细胞内p-MAPK、C-MYC和BCL-2表达降低,但BAX表达升高;TIMER 2.0数据库相关性分析,结肠癌组织中BSG表达水平与MAPK1、MYC、BCL-2表达呈现正相关,但与BAX表达呈现负相关(P<0.001)。

结论

下调CD147表达降低结肠癌细胞增殖能力,促进凋亡发生,该过程可能与抑制MAPK信号通路有关。

Objective

To investigate the effect of CD147 expression on the proliferation and apoptosis of colon cancer cells and the potential underlying molecular mechanism.

Methods

The expression level of BSG gene (encoding CD147 protein) in colon cancer was analyzed in the UCSC database, and the relationship between BSG expression and survival outcome was evaluated based on the Kaplan-Meier Plotter database. The expression of CD147 in HCT116 and HCoEPiC cells was detected by Western blot. Then, lentivirus-mediated shRNA transfection was used to down-regulate the expression of CD147 in HCT116 cells using shRNA against CD147 (shCD147), with the empty vector (sh-NON) used as the negative control. CCK-8 assay, plate clone formation assay, and Hoechst 33342 staining were used to detect cell proliferation and apoptosis. The expression of MAPK, p-MAPK, C-MYC, BAX, and BCL-2 was detected by Western blot. The correlation between the expression of BSG and MAPK1, MYC, BAX, and BCL-2 in colon cancer was analyzed based on the TIMER2.0 database.

Results

The expression of CD147 in colon cancer tissues was higher than that in normal tissues (P<0.01), and the prognosis of patients with overexpression of CD147 was poor. Western blot analysis showed that the expression of CD147 protein in HCT116 cells was increased compared with that in HCoEPiC cells (P<0.001). Under the fluorescence microscope, the fluorescence expression abundance in the shCD147 low expression group and sh-NON group could reach 90%. Western blot analysis showed that compared with untransfected HCT116 cells, the expression of CD147 protein in the shCD147 group was decreased (P<0.001). After down-regulation of CD147, cell proliferation and colony formation in the sh-CD147 group were decreased compared with untransfected HCT116 cells. The results of Hoechst 33342 staining showed that the nuclear staining of apoptosis in the shCD147 group was stronger and the fluorescence was brighter than that of untransfected HCT116 cells (P<0.001). Compared with untransfected HCT116 cells, the expression of p-MAPK, C-MYC, and BCL-2 in the sh-CD147 group was decreased, but the expression of BAX was increased. Correlation analysis based on the TIMER 2.0 database showed that the expression level of BSG in colon cancer tissue was positively correlated with the expression of MAPK1, MYC, and BCL-2, but negatively correlated with the expression of BAX (P<0.001).

Conclusion

Down-regulation of CD147 expression reduces the proliferation of colon cancer cells and promotes apoptosis, which may be related to the inhibition of the MAPK signaling pathway.

图1 结肠癌组织和细胞中CD147的表达。图a为数据库中结肠癌和正常组织中CD147的表达,与正常组相比,**P<0.01;图b为Kplan-Meier方法评估不同组样本间CD147表达差异性与预后差异的显著性,与低表达组相比,P<0.001;图c为Western blot检测CD147蛋白在HCT116、HCoEPiC的表达,与HCoEPiC细胞相比,***P<0.001
图2 结肠癌细胞内慢病毒转染效率。图a为荧光倒置显微镜下观察各组细胞的荧光表达丰度;图b为Western blot检测慢病毒转染HCT116细胞后CD147蛋白表达;与HCT116组相比,***P<0.001
图3 下调CD147表达后各组结肠癌细胞增殖、凋亡能力。图a为CCK-8实验结果;图b为细胞平板克隆实验结果;图c为Hoechst 33342染色结果蓝色,细胞核;与HCT116组相比,***P<0.001
图4 结肠癌细胞内MAPK通路中相关蛋白的表达情况。图a为Western blot检测下调CD147表达后p- MAPK、MAPK、MYC、BAX、BCL2蛋白表达;图b为TIMER 2.0数据库对结肠癌组织内基因BSG和MAPK1、MYC、BCL2的相关性分析
1
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
2
安柯, 王延召, 王子龙, 等. 青年人群结直肠癌特点分析及中西方差异对比 [J/OL]. 中华临床医师杂志(电子版), 2021, 15(2): 139-143.
3
Landras A, Reger de Moura C, Jouenne F, et al. CD147 is a promising target of tumor progression and a prognostic biomarker [J]. Cancers (Basel), 2019, 11(11): 1803.
4
Dong S, Li S, Wang X, et al. CD147 mediates 5-fluorouracil resistance in colorectal cancer by reprogramming glycolipid metabolism [J]. Front Oncol, 2022, 12: 813852.
5
Nyalali AMK, Leonard AU, Xu Y, et al. CD147: an integral and potential molecule to abrogate hallmarks of cancer [J]. Front Oncol, 2023, 13: 1238051.
6
骆文雄. CD147、MMP-2及COTL-1在结直肠癌中的表达及临床意义的研究 [D]. 南华大学, 2019.
7
Li F, Wang J, Yan YQ, et al. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway [J]. BMC Cancer, 2023, 23(1): 1214.
8
郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析 [J]. 中华肿瘤杂志, 2024, 46(3): 221-231.
9
王露尧, 张鹭鹭. 中国结直肠癌发病和死亡情况及防控策略 [J]. 解放军医院管理杂志, 2021, 28(12): 1195-1197.
10
Frick C, Rumgay H, Vignat J, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study [J]. Lancet Glob Health, 2023, 11(11): e1700-e1712.
11
Kanekura T. CD147/Basigin is involved in the development of malignant tumors and T-cell-mediated immunological disorders via regulation of glycolysis [J]. Int J Mol Sci, 2023, 24(24): 17344.
12
Zhang N, Liu Z, Lai X, et al. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway [J]. Respir Res, 2023, 24(1): 253.
13
Knutti N, Huber O, Friedrich K. CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK/STAT pathways [J]. Mol Cell Biochem, 2019, 451(1-2): 197-209.
14
Reger de Moura C, Landras A, Khayati F, et al. CD147 promotes tumor lymphangiogenesis in melanoma via PROX-1 [J]. Cancers (Basel), 2021, 13(19): 4859.
15
Li X, Xu W. CD147-mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review) [J]. Oncol Rep, 2019, 41(5): 2945-2956.
16
Guo YJ, Pan WW, Liu SB, et al. ERK/MAPK signalling pathway and tumorigenesis [J]. Exp Ther Med, 2020, 19(3): 1997-2007.
17
贾玲玲, 张文凯, 刘凯, 等. 参与调控细胞程序性死亡蛋白1及其配体1信号通路的研究进展 [J/OL].中华临床医师杂志(电子版), 2020, 14(2): 149-153.
18
Su C, Sun Q, Liu S, et al. Targeting p38γ to inhibit human colorectal cancer cell progression [J]. Biochem Biophys Res Commun, 2019, 517(1): 172-179.
[1] 孙鸿坤, 艾虹, 陈正. 内质网应激介导的牙周炎骨改建失衡的研究进展[J]. 中华口腔医学研究杂志(电子版), 2024, 18(04): 211-218.
[2] 李怡泉, 谢宇斌, 胡宏, 张燕茹, 陈图锋. 基于生物信息学分析HDAC8在结肠癌中的临床意义及其与免疫浸润的关系[J]. 中华普通外科学文献(电子版), 2024, 18(04): 275-281.
[3] 刘伟, 安杰, 智亮辉, 陈金辉. 阿帕替尼联合新辅助化疗对局部晚期结肠癌的临床疗效研究[J]. 中华普通外科学文献(电子版), 2024, 18(03): 199-203.
[4] 黄福, 王黔, 金相任, 唐云川. VEGFR2、miR-27a-5p在胃癌组织中的表达与临床病理参数及预后的关系研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 558-561.
[5] 崔宏帅, 冯丽明, 东维玲, 韩博. 腹腔镜右半结肠癌D3根治术+IGLN清扫术治疗局部进展期结肠肝曲癌的临床效果研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 566-569.
[6] 丁志翔, 于鹏, 段绍斌. 血浆BRAF基因检测对腹腔镜右半结肠癌D3根治术中行幽门淋巴结清扫的指导价值[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 570-573.
[7] 王维花, 王楠, 乔庆, 罗红. 完全腹腔镜右半结肠癌切除术两种腔内消化道重建方案对比研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(05): 574-577.
[8] 孙龙凤, 侯高峰, 王幼黎, 刘磊. 腹腔镜下右半结肠癌D3根治术中SMA或SMV入路的选择[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 438-441.
[9] 李晓鸥, 杨鹤鸣, 王国栋, 林海冠, 杨建武. 不同入路腹腔镜左半结肠癌根治术治疗效果对比[J]. 中华普外科手术学杂志(电子版), 2024, 18(04): 377-380.
[10] 李勇, 彭天明, 王倩倩, 陈育纯, 蒲小勇, 刘久敏. 基于失巢凋亡相关基因的膀胱癌预后模型构建及分析[J]. 中华腔镜泌尿外科杂志(电子版), 2024, 18(04): 331-339.
[11] 季加翠, 孙春斌, 罗恩丽. 姜黄素通过调节NF-κB/NLRP3通路减轻LPS诱导小胶质细胞神经炎症损伤[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 193-203.
[12] 曾聿理, 雷发容, 肖慧, 邱德亮, 谢静, 吴寻. 氯普鲁卡因通过调控circRNA-ZKSCAN1表达抑制肝癌Huh-7细胞体外生长和转移的研究[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 220-228.
[13] 李彦浇, 梁雷, 金钫, 王智伟. 银杏内酯B通过调控miR-24-3p对人牙周膜干细胞增殖、成骨分化的影响[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(04): 229-235.
[14] 李晶, 潘侠, 周芳, 汪晶, 洪佳. 普鲁卡因通过上调lncRNA DGCR5抑制胃癌细胞增殖、迁移和侵袭[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 151-158.
[15] 刘杜先, 张杰东, 付鲁渝, 熊志强, 龚程, 张小雅, 高明悦, 孟俊宏, 刘兰侠. 沉默circXPO1抑制肝癌细胞恶性生物学行为[J]. 中华细胞与干细胞杂志(电子版), 2024, 14(03): 159-166.
阅读次数
全文


摘要